Dr. Steven Patierno, PhD

Dr. Steven Patierno, PhD

Chairman of the Medical Advisory Board

Dr. Steven Patierno is the Deputy Director Duke Cancer Institute and Curaleaf board member. Dr. Patierno holds titles in the scientific community including Deputy Director, Duke Cancer Institute, Professor of Medicine, Professor of Pharmacology and Cancer Biology, and Professor of Community and Family Medicine, Duke University School of Medicine. As Deputy Director of the Duke Cancer Institute, Dr. Patierno helps lead a top-ranked NCI-designated Comprehensive Cancer Center dedicated to providing compassionate care from diagnosis to treatment to survivorship, advancing multi- and transdisciplinary cancer research and engaging in prevention and community health programming. One of the original eight NCI-designated comprehensive cancer centers, the Duke Cancer Institute is one of only 41 such centers in the U.S., with more than 65,000 patient visits and 6,500 new cancer diagnoses annually and nearly 1,000 active clinical trials. The Duke Cancer Institute includes more than 360 investigators with more than $225 million in annual cancer research funding. Prior to joining the Duke Cancer Institute, Dr. Patierno served as Executive Director of the George Washington University Cancer Center, Vivian Gill Distinguished Professor of Oncology, and Professor of Pharmacology and Physiology, Genetics and Urology in the GWU School of Medicine and Health Sciences. Dr. Patierno has a B.S. from The University of Connecticut and a PhD from The University of Texas Health Science Center in Houston.

Dr. Robert Schnoll, PhD

Dr. Robert Schnoll, PhD

Member of the Medical Advisory Board

Dr. Robert Schnoll serves as Program Co-Leader at the Abramson Cancer Center of the University of Pennsylvania. He is an Associate Professor of Psychiatry and an internationally recognized expert in risk prevention and intervention, epidemiology, patient education and counseling, tobacco addiction, nicotine dependence and treatment, and national health policy and ethics.

Dr. Brian F. Thomas

Dr. Brian F. Thomas

Member of the Medical Advisory Board

Dr. Brian F. Thomas has over 25 years of experience in analytical chemistry and pharmacology, servicing as principal investigator on various research mandates at the only federally approved cannabis research center in the U.S., the National Institute of Drug Abuse (NIDA) in Mississippi. Dr. Thomas has provided expertise in pharmacology and analytical chemistry to a diverse group of organizations including the Food and Drug Administration (FDA), the National Institute of Environmental Health Services (NIEHS) and the Drug Enforcement Administration (DEA).

Dr. David Casarett, MD

Dr. David Casarett, MD

Member of the Medical Advisory Board

Nationally recognized for his work in palliative care and end-of-life medicine, Dr. Casarett is Chief of Palliative Care Services for Duke University Health System, and Chief of the section of Palliative Care within the Division of General Internal Medicine. Formerly, Dr. Casarett was a Professor of Medicine at the University of Pennsylvania Perelman School of Medicine, and Director of Hospice and Palliative Care at the University of Pennsylvania Health System.